ASI Global Equity Fund Z AccRegister to Unlock Ratings |
Performance History | 30/04/2018 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 7.1 | -6.9 | 30.0 | 13.9 | -2.2 | |
+/-Cat | -1.8 | -13.0 | 9.7 | -3.1 | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 11/05/2018 | GBX 288.85 | |
Day Change | 0.83% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
IA (formerly IMA) Sector | Global | |
ISIN | GB00B1CDBF59 | |
Fund Size (Mil) 16/04/2024 | GBP 222.24 | |
Share Class Size (Mil) 29/03/2018 | GBP 0.00 | |
Max Initial Charge | - | |
Ongoing Charge 11/05/2021 | 0.51% |
Investment Objective: ASI Global Equity Fund Z Acc |
To generate growth over the long term (5 years or more) by investing in equities (company shares) worldwide. The fund will invest at least 80% in equities and equity related securities of companies listed on global stock exchanges. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Martin Connaghan 19/03/2001 | ||
Samantha Fitzpatrick 01/03/2001 | ||
Inception Date 12/10/2006 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI+3% NR GBP | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for ASI Global Equity Fund Z Acc | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 4.64 |
Taiwan Semiconductor Manufacturi... | Technology | 3.50 |
Boston Scientific Corp | Healthcare | 3.26 |
Amazon.com Inc | Consumer Cyclical | 3.12 |
AstraZeneca PLC | Healthcare | 3.08 |
Increase Decrease New since last portfolio | ||
ASI Global Equity Fund Z Acc |